Skip to main content

Digital Surgery Technologies Market Segmentation & Forecast by 2030

 The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030. The increasing complexities in clinical decision making, rising surgeon’s workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the surgeons’ reluctance toward the adoption of advanced technologies, such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on the digital surgery technologies market in the next five years, and the market will grow multifold.

The global digital surgery technologies market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of AI in healthcare, the manufacturers in the market have an ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

 

Market Segmentation

  • Product Type – Surgical Simulation, Surgical Navigation, Advanced Visualization Products, Surgical Data Science, and Surgical Planning
  • Technology Type- AI algorithms, Augmented Reality (AR)/ Virtual Reality (VR), Mixed Reality (MR), and Other Technologies


Regional Segmentation

  • North America- U.S. and Canada
  • Europe- Germany, U.K, Italy, Spain, France, and Rest-of-Europe
  • Asia-Pacific- Japan, China, South Korea, Australia, India and Rest-of-Asia-Pacific
  • Rest-of-the-World


Growth Drivers

  • Enhanced Accuracy, Promising Recovery from Pre-operative Surgical Planning
  • Results Based on Quantifiable Data
  • Increasing Interest of Technologist and Start-Ups

Market Challenges

  • Minimal Healthcare Budget Allocation for Digital Surgery Technologies
  • Impact of the Backlog in Elective Surgery Posing as a Major Challenge
  • Requirement of Additional Surgical Training
  • Requirement of Transparent Regulatory Guidelines, and Reimbursement Policies for AI/ML based medical device/Algorithm.


Market Opportunities

Promising growth opportunities for remote care, and telepresence.


Key Companies Profiled

Osso VR, Augmedics Ltd., Brainlab AG, Medtronic plc, Caresyntax, Inc., 3Dintegrated ApS, DASH Analytics, Novadaq Technologies, Inc., Fundamental VR, EchoPixel, Inc., Surgical Science Sweden AB., VirtaMed AG, Mimic Technologies, and Centerline Biomedical

 

Get Sample Report - https://bisresearch.com/requestsample?id=1013&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more